| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A national cross-sectional study of dentists' vaccine hesitancy and intention to provide HPV vaccines following emergency COVID-19 vaccination authorization
|
Flynn, Priscilla M.
|
|
|
53 |
C |
p.
|
artikel
|
| 2 |
An LNP-mRNA vaccine protects fish against rhabdovirus infection
|
Ayad, Camille
|
|
|
53 |
C |
p.
|
artikel
|
| 3 |
A novel approach using IFNAR1 KO mice for assessing Akabane virus pathogenicity and vaccine efficacy
|
Na, Eun-Jee
|
|
|
53 |
C |
p.
|
artikel
|
| 4 |
A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector
|
Niu, Yixin
|
|
|
53 |
C |
p.
|
artikel
|
| 5 |
Anticipated impact of novel adult-specific pneumococcal conjugate vaccine
|
Joshi, R.
|
|
|
53 |
C |
p.
|
artikel
|
| 6 |
A phase 3 study of 20-valent pneumococcal conjugate vaccine in healthy toddlers previously vaccinated in infancy with 13-valent pneumococcal conjugate vaccine
|
Martinón-Torres, Federico
|
|
|
53 |
C |
p.
|
artikel
|
| 7 |
A replicon-based COVID-19 vaccine candidate delivered by tobacco mosaic virus-like particles
|
Karan, Sweta
|
|
|
53 |
C |
p.
|
artikel
|
| 8 |
Assessing the geographic and socioeconomic determinants of vaccine coverage in Ethiopia: A spatial and multistage analysis at the district level
|
Forzy, Tom
|
|
|
53 |
C |
p.
|
artikel
|
| 9 |
Assessing the risks of current COVID-19 challenge trials systematically
|
Eyal, Nir
|
|
|
53 |
C |
p.
|
artikel
|
| 10 |
A synthetic peptide vaccine induces protective immune responses against Candida albicans infection in immunocompromised mice
|
Diez, Ander
|
|
|
53 |
C |
p.
|
artikel
|
| 11 |
Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents
|
Sasankan, S.
|
|
|
53 |
C |
p.
|
artikel
|
| 12 |
Binding and neutralising antibodies to respiratory syncytial virus and influenza A virus in serum and bronchoalveolar lavage fluid of healthy adults in the United States: A cross-sectional study
|
Raja, Amber I.
|
|
|
53 |
C |
p.
|
artikel
|
| 13 |
Bioengineered ClearColi™-derived outer membrane vesicles displaying CT26 neoepitopes as potent vaccine adjuvants against colon carcinoma in a preventive mouse model
|
Sharif, Elham
|
|
|
53 |
C |
p.
|
artikel
|
| 14 |
Community pharmacists' pneumococcal vaccine knowledge and perceived barriers to vaccination
|
Davies, Abby
|
|
|
53 |
C |
p.
|
artikel
|
| 15 |
Considering recombinant herpes zoster vaccine for fragile pediatric patients: A new opportunity
|
Mollo, A.
|
|
|
53 |
C |
p.
|
artikel
|
| 16 |
Corrigendum to, “Attitudes and beliefs of healthcare providers toward vaccination in the United States: A cross-sectional online survey” [Vaccine (2024) Dec 2 42(26) 126437]
|
Eiden, Amanda L.
|
|
|
53 |
C |
p.
|
artikel
|
| 17 |
Corrigendum to “Detection of rotavirus before and after monovalent rotavirus vaccine introduction and vaccine effectiveness among children in mainland tanzania” [Vaccine 36(47) (2018 Nov 12) 7149–7156]
|
Jani, B.
|
|
|
53 |
C |
p.
|
artikel
|
| 18 |
Corrigendum to the article titled, “Attitudes and beliefs about vaccination among adults in the United States: A real-world, cross-sectional, web-based survey study” [Vaccine 50 (2025) 126807]
|
Eiden, Amanda L.
|
|
|
53 |
C |
p.
|
artikel
|
| 19 |
Corrigendum to The origin of vaccine nationalism [Vaccine 51 (2025) 126897]
|
Shao, Qi
|
|
|
53 |
C |
p.
|
artikel
|
| 20 |
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
|
Keeling, Matt J.
|
|
|
53 |
C |
p.
|
artikel
|
| 21 |
COVID-19 vaccination rates among pregnant women in France: A nationwide cohort study
|
Bernard, Clément
|
|
|
53 |
C |
p.
|
artikel
|
| 22 |
COVID-19 vaccination uptake in people experiencing homelessness during the first three years of the global COVID-19 vaccination effort: A systematic review and meta-analysis
|
McCosker, Laura K.
|
|
|
53 |
C |
p.
|
artikel
|
| 23 |
COVID-19 vaccine decision-making and the role of institutions across the pandemic in UK Black African and Black Caribbean communities
|
Shearn, Christina
|
|
|
53 |
C |
p.
|
artikel
|
| 24 |
Designing a National Rapid Vaccine Coverage Survey in low-resource settings: Experiences from the Democratic Republic of the Congo 2018–2023
|
Mafuta, Eric M.
|
|
|
53 |
C |
p.
|
artikel
|
| 25 |
Development and validation of a clinical prediction tool for non-receipt of updated COVID-19 vaccines
|
Bruxvoort, Katia J.
|
|
|
53 |
C |
p.
|
artikel
|
| 26 |
Differences in seasonal influenza vaccine hesitancy profiles between clinicians practicing traditional Chinese medicine and modern Western medicine: A national cross-sectional survey
|
Zhang, Liuren
|
|
|
53 |
C |
p.
|
artikel
|
| 27 |
Editorial Board
|
|
|
|
53 |
C |
p.
|
artikel
|
| 28 |
Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2
|
Kadoi, Kenji
|
|
|
53 |
C |
p.
|
artikel
|
| 29 |
Erratum to “Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010–2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening” [Vaccine 54 (2025) 126986].
|
Yuill, Susan
|
|
|
53 |
C |
p.
|
artikel
|
| 30 |
Evaluation of novel single-dose vaccine candidates against gonadotropin-releasing hormone (GnRH) in mice
|
Shalash, Ahmed O.
|
|
|
53 |
C |
p.
|
artikel
|
| 31 |
Exploring TLR agonists as adjuvants for COVID-19 oral vaccines
|
Félix, Paulo
|
|
|
53 |
C |
p.
|
artikel
|
| 32 |
Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis
|
Zhao, Tianshuo
|
|
|
53 |
C |
p.
|
artikel
|
| 33 |
Human papillomavirus awareness, vaccination rate, and sociodemographic covariates of vaccination status in a low-income country: A cross-sectional study in the rural Busoga region of Uganda
|
Einarson, Troels Alnor
|
|
|
53 |
C |
p.
|
artikel
|
| 34 |
Identification of a conserved cryptic epitope with cross-immunoreactivity in outer membrane protein K (OmpK) from Vibrio species
|
Lun, Jingsheng
|
|
|
53 |
C |
p.
|
artikel
|
| 35 |
Identification of immunogenic outer membrane vesicle vaccine antigen components using a meningococcal protein microarray
|
Ramirez-Bencomo, F.
|
|
|
53 |
C |
p.
|
artikel
|
| 36 |
“If I know about it of course I would give my son and daughter”, barriers to and enablers of accessing human papillomavirus vaccination among women from refugee and asylum-seeking backgrounds resettling in Melbourne, Australia – A qualitative study
|
Davidson, Natasha
|
|
|
53 |
C |
p.
|
artikel
|
| 37 |
Immunogenicity of inactivated quadrivalent influenza vaccine in pregnant women, including the level of postvaccination antibodies in umbilical cord blood
|
Zasztowt-Sternicka, Monika
|
|
|
53 |
C |
p.
|
artikel
|
| 38 |
Immunogenicity of pre-exposure rabies vaccination comparing number of doses and routes of administration: A systematic review and meta-analyses
|
Davis, Phaedra
|
|
|
53 |
C |
p.
|
artikel
|
| 39 |
Immunostimulant effect of heat-inactivated Mycobacterium bovis in mice challenged with vector-borne pathogens
|
Ferreras-Colino, Elisa
|
|
|
53 |
C |
p.
|
artikel
|
| 40 |
Increasing confidence for pediatric COVID-19 and influenza vaccines using messages affirming parental autonomy: A randomized online experiment
|
Cotter, Lynne M.
|
|
|
53 |
C |
p.
|
artikel
|
| 41 |
In-silico and experimental analysis of Klebsiella pneumoniae fimbriae subunits for vaccine development
|
Assoni, Lucas
|
|
|
53 |
C |
p.
|
artikel
|
| 42 |
In vitro evaluation of multi-protein chimeric antigens in effectively clearing the blood stage of Plasmodium falciparum
|
Deshmukh, Bhagyashree
|
|
|
53 |
C |
p.
|
artikel
|
| 43 |
Lessons for polio eradication from the geographic variations of vaccine efficacy of oral polio
|
John, T. Jacob
|
|
|
53 |
C |
p.
|
artikel
|
| 44 |
Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets
|
Chen, Po-Ling
|
|
|
53 |
C |
p.
|
artikel
|
| 45 |
Microarray patch vaccines for typhoid conjugate vaccines: A global cost-effectiveness analysis
|
Antillon, Marina
|
|
|
53 |
C |
p.
|
artikel
|
| 46 |
Novel tuberculosis vaccines based on TB10.4 and Ag85B: State-of-art and advocacy for good practices
|
Tengattini, Sara
|
|
|
53 |
C |
p.
|
artikel
|
| 47 |
Partnering with social media influencers to promote HPV vaccination in diverse communities
|
Leader, Amy E.
|
|
|
53 |
C |
p.
|
artikel
|
| 48 |
Pertussis seroepidemiology in mother-newborn pairs during an epidemic period in China, 2024
|
Chen, Xiaoli
|
|
|
53 |
C |
p.
|
artikel
|
| 49 |
Prioritization and barriers of mpox vaccination uptake among gay, bisexual and other men who have sex with men in Taiwan: 2023 HEART survey
|
Strong, Carol
|
|
|
53 |
C |
p.
|
artikel
|
| 50 |
Projecting maximum potential demand for nirsevimab to protect eligible US infants and young children against respiratory syncytial virus in the 2024/2025 season
|
Olesen, Scott W.
|
|
|
53 |
C |
p.
|
artikel
|
| 51 |
Real-world effectiveness of influenza vaccination in preventing influenza and influenza-like illness in children
|
Rigamonti, Vera
|
|
|
53 |
C |
p.
|
artikel
|
| 52 |
Reasons for COVID-19 vaccination late in the pandemic: A qualitative study
|
Fisher, Kimberly A.
|
|
|
53 |
C |
p.
|
artikel
|
| 53 |
Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspective
|
Chan, Mei Xuan Jessalyn
|
|
|
53 |
C |
p.
|
artikel
|
| 54 |
Religious group membership and conspiracy beliefs influence vaccine uptake: Insights from 20 European countries
|
Foran, Aoife-Marie
|
|
|
53 |
C |
p.
|
artikel
|
| 55 |
Respiratory syncytial virus vaccine uptake among adults aged ≥60 years in a large, integrated healthcare system in Southern California 2023–2024
|
Patrick, Rudy
|
|
|
53 |
C |
p.
|
artikel
|
| 56 |
Sabin inactivated polio vaccine upstream process development using fixed-bed bioreactor technology
|
Hamidi, Ahd
|
|
|
53 |
C |
p.
|
artikel
|
| 57 |
Safety, immunogenicity and immune persistence of a lyophilized purified human diploid cells rabies vaccine following rabies PEP regimen Essen and Zagreb: A randomized, blinded controlled phase 3 trial in healthy participants aged 10–60 years old
|
Li, Guifan
|
|
|
53 |
C |
p.
|
artikel
|
| 58 |
Safety monitoring of health outcomes following influenza vaccination during the 2023–2024 season among U.S. Medicare beneficiaries aged 65 years and older
|
Lloyd, Patricia C.
|
|
|
53 |
C |
p.
|
artikel
|
| 59 |
Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron
|
Meeraus, Wilhelmine
|
|
|
53 |
C |
p.
|
artikel
|
| 60 |
Sow vaccination with a novel recombinant protein vaccine protects piglets against Streptococcus suis infection
|
Frosth, Sara
|
|
|
53 |
C |
p.
|
artikel
|
| 61 |
The lack of a biorepository during vaccine trials: A lost opportunity to understand staphylococcal immunity
|
Proctor, Richard A.
|
|
|
53 |
C |
p.
|
artikel
|
| 62 |
Vaccine hesitancy in the vaccination of children in Brazil
|
França, Ana Paula
|
|
|
53 |
C |
p.
|
artikel
|
| 63 |
What is the quality of evidence informing vaccine clinical practice recommendations in Australia?
|
Dymock, Michael
|
|
|
53 |
C |
p.
|
artikel
|
| 64 |
Workshop report: One Health challenges and knowledge gaps in the control of intracellular infections with a focus on tuberculosis and leishmaniasis
|
Miller, Michele
|
|
|
53 |
C |
p.
|
artikel
|
Tijdschrift beschrijving